Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra J Zack

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Current Rheumatology Reports|February 11, 2021
A Review of Complement Activation in SLEArthur Weinstein, Roberta V Alexander, Debra J Zack
The Journal of International Medical Research|June 28, 2013
Associations between inflammation, nocturnal back pain and fatigue in ankylosing spondylitis and improvements with etanercept therapyMohammed Hammoudeh, Debra J Zack, Wenzhi Li, et al.
Advances in Experimental Medicine and Biology|October 31, 2007
RANKL inhibition: from mice to men (and women)Marina Stolina, Paul J Kostenuik, William C Dougall, et al.
Annals of the Rheumatic Diseases|December 1, 2011
The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic reviewClaire Bombardier, Marco Barbieri, Anju Parthan, et al.
Pediatric Rheumatology Online Journal|June 16, 2010
Summary of worldwide pediatric malignancies reported after exposure to etanerceptPeter McCroskery, Carol A Wallace, Daniel J Lovell, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 20, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritisMarina Stolina, Brad Bolon, Denise Dwyer, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatmentVibeke Strand, Veronika Sharp, Andrew S Koenig, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2013
Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohortJoseph A Markenson, Andrew S Koenig, Jing Yuan Feng, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2022
Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosusTyler O'Malley, Fenglong Xie, Yujie Su, et al.
Arthritis and Rheumatism|October 4, 2005
Analysis of the kinetics of osteoclastogenesis in arthritic ratsGeorg Schett, Marina Stolina, Brad Bolon, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Current Rheumatology Reports|February 11, 2021
A Review of Complement Activation in SLEArthur Weinstein, Roberta V Alexander, Debra J Zack
The Journal of International Medical Research|June 28, 2013
Associations between inflammation, nocturnal back pain and fatigue in ankylosing spondylitis and improvements with etanercept therapyMohammed Hammoudeh, Debra J Zack, Wenzhi Li, et al.
Advances in Experimental Medicine and Biology|October 31, 2007
RANKL inhibition: from mice to men (and women)Marina Stolina, Paul J Kostenuik, William C Dougall, et al.
Annals of the Rheumatic Diseases|December 1, 2011
The relationship between joint damage and functional disability in rheumatoid arthritis: a systematic reviewClaire Bombardier, Marco Barbieri, Anju Parthan, et al.
Pediatric Rheumatology Online Journal|June 16, 2010
Summary of worldwide pediatric malignancies reported after exposure to etanerceptPeter McCroskery, Carol A Wallace, Daniel J Lovell, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|December 20, 2008
The evolving systemic and local biomarker milieu at different stages of disease progression in rat collagen-induced arthritisMarina Stolina, Brad Bolon, Denise Dwyer, et al.
Annals of the Rheumatic Diseases|January 20, 2012
Comparison of health-related quality of life in rheumatoid arthritis, psoriatic arthritis and psoriasis and effects of etanercept treatmentVibeke Strand, Veronika Sharp, Andrew S Koenig, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|August 23, 2013
Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohortJoseph A Markenson, Andrew S Koenig, Jing Yuan Feng, et al.
Journal of Managed Care & Specialty Pharmacy|July 1, 2022
Complement activation products vs standard ANA testing: Treatment outcomes, diagnosis, and economic impact (CAPSTONE) in systemic lupus erythematosusTyler O'Malley, Fenglong Xie, Yujie Su, et al.
Arthritis and Rheumatism|October 4, 2005
Analysis of the kinetics of osteoclastogenesis in arthritic ratsGeorg Schett, Marina Stolina, Brad Bolon, et al.
Pageof 2